Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB

• المؤلفون الرئيسيون: Chang, Zi Wei, Goh, Yun Shan, Rouers, Angeline, Fong, Siew-Wai, Tay, Matthew Zirui, Chavatte, Jean-Marc, Hor, Pei Xiang, Loh, Chiew Yee, Huang, Yuling, Tan, Yong Jie, Neo, Vanessa, Kam, Isaac Kai Jie, Yeo, Nicholas Kim-Wah, Tan, Eunice X., Huang, Daniel, Wang, Bei, Siti Nazihah Mohd Salleh, Ngoh, Eve Zi Xian, Wang, Cheng-I, Leo, Yee-Sin, Lin, Raymond Tzer Pin, Lye, David C., Young, Barnaby Edward, Muthiah, Mark, Ng, Lisa F. P., Rénia, Laurent
• مؤلفون آخرون: Lee Kong Chian School of Medicine (LKCMedicine)
• التنسيق: مقال
• اللغة: English
• منشور في: 2023
• الموضوعات: Science::Medicine; SARS-CoV-2; Spike Protein
• الوصول للمادة أونلاين: https://hdl.handle.net/10356/171510
• المؤسسة: Nanyang Technological University

Vaccine immunogenicity in transplant recipients can be impacted by the immunosuppressive (IS) regimens they receive. While BNT162b2 vaccination has been shown to induce an immune response in liver transplant recipients (LTRs), it remains unclear how different IS regimens may affect vaccine immunogen...